OHR Pharmaceutical (OHRP) Trading Down 5.3%
OHR Pharmaceutical Inc (NASDAQ:OHRP) shares traded down 5.3% during trading on Thursday . The stock traded as low as $0.17 and last traded at $0.18. 607,443 shares were traded during trading, a decline of 50% from the average session volume of 1,206,177 shares. The stock had previously closed at $0.19.
Separately, ValuEngine raised OHR Pharmaceutical from a “hold” rating to a “buy” rating in a research note on Thursday, November 1st.
OHR Pharmaceutical (NASDAQ:OHRP) last released its earnings results on Tuesday, August 14th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter.
OHR Pharmaceutical, Inc, a clinical-stage pharmaceutical company, focuses on the development of novel therapies for the treatment of ophthalmic diseases. Its lead clinical program is topical Squalamine, a small molecule anti-angiogenic drug, which could provide a non-invasive therapy to enhance vision outcomes.
Further Reading: Stop Order
Receive News & Ratings for OHR Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OHR Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.